Patents by Inventor Lucie Jetté

Lucie Jetté has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140171507
    Abstract: The invention relates to compounds, to compositions comprising the same and uses thereof for the prevention or treatment of pain, e.g neuropathic pain while having neutral or beneficial effect on metabolic parameters.
    Type: Application
    Filed: September 6, 2013
    Publication date: June 19, 2014
    Inventors: Xianqi KONG, Nigel LEVENS, Serge LAMOTHE, Mohammed ATFANI, Stephane CIBLAT, Lucie JETTE
  • Publication number: 20120208876
    Abstract: The invention relates to compounds, to compositions comprising the same and uses thereof for the prevention or treatment of pain, e.g neuropathic pain while having neutral or beneficial effect on metabolic parameters.
    Type: Application
    Filed: November 4, 2011
    Publication date: August 16, 2012
    Inventors: Xianqi KONG, Nigel LEVENS, Serge LAMOTHE, Mohamed ATFANI, Stephane CIBLAT, Lucie JETTE
  • Publication number: 20100048545
    Abstract: The invention relates to 4-hydroxyisoleucine, isomers, analogs, lactones, salts, and prodrugs thereof, to processes for their preparation, and to pharmaceutical compositions comprising the same. More particularly, the invention relates to the use of those compounds in the prevention and treatment of disorders of fat metabolism and related syndromes. The invention further relates to the use of those compounds in the prevention and treatment of obesity and related syndromes including, but not limited to, the cosmetic treatment of a mammal in order to effect a cosmetically beneficial loss of body weight, and more particularly loss of body fat.
    Type: Application
    Filed: March 22, 2007
    Publication date: February 25, 2010
    Applicant: INNODIA INC.
    Inventors: Lucie Jette, Patricia Mcnicol, Manjinder Gill, André Marette
  • Patent number: 7268113
    Abstract: This invention relates to growth hormone releasing factor (GRF) derivatives. In particular, this invention relates to GRF peptide derivatives having an extended in vivo half-life, for promoting the endogenous production or release of growth hormone in humans and animals.
    Type: Grant
    Filed: February 1, 2002
    Date of Patent: September 11, 2007
    Assignee: ConjuChem Biotechnologies Inc.
    Inventors: Dominique P. Bridon, Nissab Boudjellab, Roger Léger, Martin Robitaille, Lucie Jetté, Corinne Benquet
  • Publication number: 20060223884
    Abstract: The invention relates to 4-hydroxyisoleucine, isomers, analogs, lactones, salts, and prodrugs thereof, to processes for their preparation, and to pharmaceutical compositions comprising the same. More particularly, the invention relates to the use of those compounds in the prevention and treatment of obesity and related syndromes.
    Type: Application
    Filed: March 22, 2006
    Publication date: October 5, 2006
    Inventors: Nicolas Chapal, Patricia McNicol, Lucie Jette
  • Publication number: 20030073630
    Abstract: This invention relates to growth hormone releasing factor (GRF) derivatives. In particular, this invention relates to GRF peptide derivatives having an extended in vivo half-life, for promoting the endogenous production or release of growth hormone in humans and animals.
    Type: Application
    Filed: August 12, 2002
    Publication date: April 17, 2003
    Inventors: Dominique P. Bridon, Nissab Boudjellab, Roger Leger, Martin Robitaille, Lucie Jette, Corinne Benquet